President and CEO

Inhibikase Therapeutics Announces Appointment of David McIntyre as Chief Financial Officer

Braeburn gets FDA approval for opioid use disorder drug after more than 4-year battle

FDA clears Braeburn's long-acting Brixadi to treat opioid use disorder

Camurus announces that Braeburn resubmits NDA for Brixadi™ in the US

Manager, Pricing and Contracting

Braeburn is dedicated to delivering solutions for people living with opioid use disorder. The Manager of Pricing and Contracting will support the core business with execution of pricing and contracting strategy, including gross-to-net projections and contract performance reviews, while collaborating with Market Access leadership and other departments.

Sign up with Google

Sign in with Google